February 24, 2026
Market insights predict the global antibody drug conjugate (ADC) industry will increase from USD 13.51 billion in 2025 to USD 32.66 billion by 2035, achieving a CAGR of 9.23%. The rising number of cancer cases and the rising need for safe, efficient ...
February 27, 2026
Our projections indicate that, the antibody-drug conjugates (ADCs) CMO and CDMO market was valued at USD 9.93 billion in 2025 and reached USD 11.08 billion in 2026, and it is projected to grow to USD 29.65 billion by 2035, expanding at a CAGR of 11.5...
April 21, 2026
The U.S. oncology pharmaceutical market is expanding due to increasing cancer awareness as well as growing cancer drug development. ...
April 21, 2026
According to market projections, the global modified antibody market, valued at USD 3.10 billion in 2025, is anticipated to reach USD 7.36 billion by 2035, growing at a CAGR of 9.04% over the next decade. The biopharmaceutical contract manufacturin...
February 17, 2026
According to market projections, the global bispecific antibody market, valued at USD 17.24 billion in 2025, is anticipated to reach USD 662.84 billion by 2035, growing at a CAGR of 44.04% over the next decade. The bispecific antibody market is expan...
April 21, 2026
The antibody optimization service market was valued at USD 2.77 billion in 2024 and is projected to reach USD 6.07 billion by 2034, growing at a CAGR of 8.45%. The report covers technology segments (CRISPR, TALEN, ZFN) and applications (therapeutics,...
April 24, 2026
Non-Antibody Fusion Proteins Market (By Product Type: Receptor Fusion Proteins, Enzyme Fusion Proteins, Ligand Fusion Proteins, Scaffold-Based Fusion Proteins; By Therapeutic Application: Oncology, Autoimmune & Inflammatory Diseases, Infectious D...
January 22, 2026
According to our insight, the U.S. antibody specificity testing market was valued at USD 343.71 million in 2025 and is projected to grow from USD 369.18 million in 2026 to nearly USD 702.49 billion by 2035, expanding at a CAGR of 7.41% during the for...
February 05, 2026
According to our forecasts, the humanized monoclonal antibody market was valued at USD 170.04 billion in 2025 and is projected to reach USD 190.34 billion in 2026, expanding to USD 525.3 billion by 2035 at a CAGR of 11.94% from 2026 to 2035....
April 21, 2026
The next-generation bispecific antibody market is expanding due to increasing diseases as well as rising autoimmune diseases treatment approaches. North America led the market due to the presence of well-developed industries....
March 26, 2026
Based on market forecasts, the U.S. bispecific antibody sector will expand from USD 11.2 billion in 2025 to USD 448.62 billion by 2035, experiencing a CAGR of 44.52%. The market is driven by the emergence of next-generation technologies and advances ...
March 16, 2026
Projections indicate that, the global antibody discovery market will increase from USD 9.1 billion in 2025 to USD 22.64 billion by 2035, experiencing a CAGR of 9.54% over the next 10 years. Rising prevalence of chronic and infectious diseases has est...
April 21, 2026
According to market projections, the global human combinatorial antibody libraries market, valued at USD 116.2 billion in 2024, is anticipated to reach USD 189.57 billion by 2034, growing at a CAGR of 5.04% over the next decade. The human combinatori...
February 09, 2026
According to market projections, the monoclonal antibody for asthma and COPD sector is expected to grow from USD 34.02 billion in 2025 to USD 58.94 billion by 2035, reflecting a CAGR of 5.65%, providing detailed analysis of disease-specific segment...
April 21, 2026
According to market projections, the global complement C4 antibody market, valued at USD 21.56 billion in 2024, is anticipated to reach USD 68.48 billion by 2034, growing at a CAGR of 12.25% over the next decade. The demand for complement C4 antibodi...
April 21, 2026
Based on market forecasts, the global antibody therapy market, projected at USD 278.25 billion in 2024, is expected to reach USD 951.24 billion by 2034, growing at a CAGR of 13.08% over the forecast period. The antibody therapy market is expanding du...
April 21, 2026
According to market projections, the monoclonal antibody discovery platform sector is expected to grow from USD 3.66 billion in 2025 to USD 11.93 billion by 2035, reflecting a CAGR of 12.55% that covers manufacturers, suppliers, value chain insights,...
April 21, 2026
According to market projections, the global epigenetic antibodies market, valued at USD 2.29 billion in 2024, is anticipated to reach USD 12.01 billion by 2034, growing at a CAGR of 18.04% over the next decade.The epigenetic antibodies market is grow...
April 21, 2026
Projections indicate that, the global protein expression technology market will increase from USD 2.85 billion in 2024 to USD 5.58 billion by 2034, experiencing a CAGR of 6.94% over the next 10 years. The protein expression technology market is expan...
April 21, 2026
Projections indicate that, innovative drug CRO industry is projected to rise from USD 56.56 billion in 2025 to USD 96.06 billion by 2035, reflecting a CAGR of 5.44% over the next decade. The growing demand for personalized medicines and technological...
April 21, 2026
The pharmacovigilance market is valued at USD 9.61 billion in 2026 and is projected to reach USD 16.87 billion by 2035, expanding at a CAGR of 6.45%.This market report covers detailed segmentation by service type with case processing leading at 31.3%...
April 21, 2026
Market insights predict, the topical antibiotic drug industry is expected to grow from USD 5.65 billion in 2024 to USD 9.59 billion by 2034, driven by a CAGR of 5.45%. The market is growing globally due to increasing skin infections, rising antimicro...
April 21, 2026
Market insights predict, the compound management industry is expected to grow from USD 492.14 million in 2024 to USD 1899.41 million by 2034, driven by a CAGR of 14.51%. The compound management market is expanding due to growing outsourcing tre...
January 09, 2026
Market insights predict, the antibodies drug industry is expected to grow from USD 272.3 billion in 2025 to USD 759.36 billion by 2035, driven by a CAGR of 10.8%. The increase in the production of monoclonal antibodies is leading to higher demand for...
February 09, 2026
The global GMP drug substance market was USD 2.71 billion in 2025 and is projected to reach USD 4.91 billion by 2035 at a CAGR of 6.14%. Key segments include viral vectors, cell-based therapies, oligonucleotides, and biologics. North America leads,...
April 21, 2026
Projections indicate that, small nucleic acid drug industry is projected to rise from USD 5.94 billion in 2024 to USD 33.28 billion by 2034, reflecting a CAGR of 18.84% over the next decade. The rising prevalence of chronic disorders and the growing ...
April 21, 2026
According to forecasts, the global drug-induced dyskinesia market will grow from USD 418 million in 2024 to USD 627.5 million by 2034, with an expected CAGR of 4.34%. The market is growing due to the rising prevalence of Parkinsons disease and increa...
April 21, 2026
The robotics in drug discovery market is growing due to rising demand for faster, accurate research and reduced human error. Automation accelerated high-throughput screening and improved efficacy in early-stage drug development....
February 09, 2026
According to our projections, the bulk-drug compounding market was valued at USD 12.52 billion in 2025 and reached USD 13.18 billion in 2026, and it is projected to grow to USD 20.87 billion by 2035 at a CAGR of 5.24% during 2026–2035....
April 21, 2026
Based on market forecasts, the pemphigus vulgaris sector will expand from USD 530.43 million in 2025 to USD 1171.93 million by 2035, experiencing a CAGR of 8.25%. The pemphigus vulgaris market is growing due to increasing clinical trials aimed at dev...
April 21, 2026
Market insights predict the global drug-loaded fat emulsion industry will increase from USD 2.34 billion in 2024 to USD 7.25 billion by 2034, achieving a CAGR of 12.04%. The principal advantages of these delivery systems, including versatile administ...
February 23, 2026
According to projections, the global topical drug delivery market, valued at USD 268.96 billion in 2025, is anticipated to reach USD 622.85 billion by 2035, growing at a CAGR of 8.76% over the next decade. A widespread increase in cases of div...
April 21, 2026
Forecasts suggest that the small molecule CDMO market will expand from USD 72.81 billion in 2024 to USD 145.12 billion by 2034, with a CAGR of 7.14% during this period. In 2024, North America led the small molecule CDMO market, with APIs holding the ...
January 23, 2026
According to our insight calculates, the animal drug compounding market was valued at USD 1.82 billion in 2026 and is projected to reach USD 3.73 billion by 2035, expanding at a CAGR of 8.32% from 2026 to 2035....
April 21, 2026
According to market projections, the global generic drug CRO market, valued at USD 8.45 billion in 2024, is anticipated to reach USD 11.73 billion by 2034, growing at a CAGR of 3.36% over the next decade. The generic drug CRO market is growing due to...
April 21, 2026
Market insights predict the global blood-brain barrier industry will increase from USD 6.03 billion in 2025 to USD 55.45 billion by 2035, achieving a CAGR of 24.85%.The rising prevalence of neurological disorders and advances in neuroscience technolo...
April 21, 2026
The compounded topical drug market is growing due to increasing skin disorders affecting 1.8 billion people, personalized medicine demands, and drug shortages. Compounding allows for tailored medications without allergens. Key trends include Medisca'...
April 21, 2026
The Hair Treatment Drug Market is growing as hair loss, driven by factors like hormonal imbalances, immune disorders, and pollution, impacts many. Treatments include OTC options like biotin, zinc, and tea tree oil, while prescribed drugs like minoxid...
April 21, 2026
According to market projections, the oncology drug discovery sector is growing due to the rising prevalence of cancer and increasing demand for targeted, personalized therapies. Advances in genomics and biotechnology are accelerating the development ...
April 21, 2026
Market insights predict the U.S. drug utilization management industry will increase from USD 42.80 billion in 2025 to USD 88.45 billion by 2035, achieving a CAGR of 7.53%.The growing demand for personalized care and drug safety, and favorable governm...
April 21, 2026
Based on market forecasts, the Europe life science market, projected at USD 26.32 billion in 2024, is expected to reach USD 78.90 billion by 2034, growing at a CAGR of 11.61% over the forecast period. The growing public health concerns, significant s...
April 21, 2026
According to market projections, the topical drugs CDMO sector is expected to grow from USD 46.32 billion in 2024 to USD 136.71 billion by 2034, reflecting a CAGR of 11.43%. In 2024, Asia Pacific led the topical drugs CDMO market, with Latin America ...
April 21, 2026
Based on market forecasts, the AI in drug repurposing sector will expand from USD 1.26 billion in 2025 to USD 8.12 billion by 2035, experiencing a CAGR of 20.44%.The AI in the drug repurposing market is driven by the rising demand for drugs and the n...
April 21, 2026
The peptide-based weight loss medication market is expanding due to a growing health-conscious population as well as rising muscle-preserving weight loss medications. North America led the market due to the presence of a well-developed healthcare sec...
April 21, 2026
According to market projections, the connected drug delivery devices sector is expected to grow from USD 9.18 billion in 2025 to USD 75.41 billion by 2035, reflecting a CAGR of 23.44%. The rising prevalence of chronic disorders and the growing demand...
April 23, 2026
Drug Delivery Devices Market ( By Product: Inhalers, Injection Devices, Implants, Topical Delivery System, Oral Delivery System, Infusion Pumps; By Application: Oncology, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System ...
April 15, 2026
Next-Gen Delivery System Market ( By Product Type: Oral Drug Delivery Systems, Injectable Drug Delivery Systems, Pulmonary Drug Delivery Systems, Transdermal Drug Delivery Systems, Implantable Drug Delivery Systems, Ocular Drug Delivery Systems; By T...
January 27, 2026
The computer vision for drug manufacturing market is growing due to its majorly application in pharmaceuticals, which leverages deep learning technology for quality control, visual inspection, and procedure automation, and also enhances pharmaceutica...
April 21, 2026
Projections indicate the asthma treatment market will increase from USD 27.61 billion in 2024 to USD 38.57 billion by 2034, experiencing a CAGR of 3.4% over the next 10 years. Asthma treatment focuses on controlling symptoms and preventing attacks. I...
February 10, 2026
Based on our estimations, the commercial drug manufacturing market was valued at USD 1.97 billion in 2025 and is expected to reach USD 2.08 billion in 2026, growing further to approximately USD 3.41 billion by 2035 at a CAGR of 5.64% during 2026&ndas...
April 21, 2026
According to market projections, the protein labeling sector is expected to grow from USD 2.67 billion in 2024 to USD 6.02 billion by 2034, reflecting a CAGR of 8.48%. Protein labeling is used in research and diagnosis of various diseases, which driv...
April 21, 2026
Market insights predict the global drug reference apps industry will increase from USD 1.47 billion in 2025 to USD 3.55 billion by 2035, achieving a CAGR of 9.20%. The drug reference apps market is growing due to digital transformation. North America...
April 21, 2026
Projections indicate that, mice model industry is projected to rise from USD 1.57 billion in 2024 to USD 4.1 billion by 2034, reflecting a CAGR of 10.04% over the next decade. The mice model market is rising strongly due to the growing research ...
April 21, 2026
The temperature-sensitive drug market is expanding due to increasing vaccination as well as growing demand for biosimilars. North America led the market due to the growing use of biologics....
March 31, 2026
Orphan Drug Market (By Drug Type: Biologicals, Non-Biologicals; By Therapy: Oncology, Ovarian cancer, Multiple Myeloma, Pancreatic Cancer, Renal Cell Carcinoma, Others, Hematology, Hereditary Angioedema, Hemophilia, Others, Neurology, Alzheimer...
April 21, 2026
Based on market forecasts, the oligonucleotide CDMO sector will expand from USD 2.55 billion in 2024 to USD 18.37 billion by 2034, experiencing a CAGR of 21.83%. In 2024, North America led the oligonucleotide CDMO market, with Asia Pacific poised for...
April 07, 2026
Drug Screening Market ( By Product: Consumables, Rapid Testing Devices, Instruments, Services; By Sample: Urine Sample, Oral Fluid Sample, Hair Sample, Other; By Drug: Alcohol, Cannabis/Marijuana, Cocaine, Opioids, Amphetamine & Methamphetamine, ...
April 21, 2026
Market insights predict the global dental drug industry will increase from USD 9.07 billion in 2024 to USD 17.41 billion by 2034, achieving a CAGR of 6.75%. Globally rising dental issues and cosmetic aesthetics are fueling the global market growth. T...
January 08, 2026
Based on market forecasts, the global U.S. drug screening market, projected at USD 2.80 billion in 2025, is expected to reach USD 4 billion by 2035, growing at a CAGR of 2.7% over the forecast period. The U.S. drug screening market is growing rapidly...
April 07, 2026
Biosimilars Market ( By Product: Recombinant Non-Glycosylated Proteins, Recombinant Glycosylated Proteins; By Application: Chronic & Autoimmune Disorders Oncology, Blood Disorders, Growth Hormonal Deficiency, Rheumatoid Arthritis, Others; By Regi...
February 10, 2026
Based on our research, the drug product development service market was valued at USD 340.04 million in 2025 and is projected to reach USD 350.38 million in 2026, expanding further to USD 458.76 million by 2035 at a CAGR of 3.04%....
April 21, 2026
Market insights predict the global drug designing tools industry will increase from USD 3.4 billion in 2024 to USD 7.86 billion by 2034, achieving a CAGR of 8.73%. The drug designing tools market is growing due to it is an inventive method of finding...
April 21, 2026
Based on market forecasts, the global lead optimization services in drug discovery market, projected at USD 4.26 billion in 2024, is expected to reach USD 10.26 billion by 2034, growing at a CAGR of 9.23% over the forecast period. The lead optimizati...
April 21, 2026
According to market projections, the global needle free drug delivery devices market, valued at USD 14.24 billion in 2024, is anticipated to reach USD 29.54 billion by 2034, growing at a CAGR of 7.54% over the next decade. The needle free drug delive...
April 21, 2026
Multiomics is highly essential in drug discovery because of its advantage in developing precision medicine. North America is dominating the multiomics in drug discovery market because of growing investment in biotechnology industry....
April 21, 2026
Around the world, the sex-based drug development market is driven by the rising approaches to sex-based differences, like pharmacokinetic, pharmacodynamic, and hormonal characteristics. Whereas, North America dominated the global market, with a growi...
April 15, 2026
Drug Repurposing Market (By Type of Approach: Disease-centric, Target-centric, Drug-centric; By Therapeutic Area: Same therapeutic area, Different therapeutic areas; By Drug Molecules: Biologics, Small molecule; By Region: North America, Asia Pacific...
April 21, 2026
Cell Dissociation Market (By Product: Enzymatic Dissociation, Non-enzymatic dissociation, Instruments & Accessories; By Type: Tissue Dissociation, Cell Detachment; By End-use: Pharmaceutical & Biotechnology Companies, Research & Academic ...
April 21, 2026
Market insights predict, the drug-device combination products industry is expected to grow from USD 161.78 billion in 2024 to USD 337.81 billion by 2034, driven by a CAGR of 7.64%. The rising incidences of chronic disorders, demand for personalized m...
April 21, 2026
The computer-aided drug design (CADD) market is primarily driven by the increasing need for developing new drugs. The growing new drug discovery research and technological advancements drive the market. North America led the global market owing to th...
April 24, 2026
Sterile Drug Product Testing Market ( By Test Type: Sterility Testing, Endotoxin Testing, Particulate Matter Testing, Container Closure Integrity Testing, Bioburden Testing; By Product and Service Type: Instruments, Reagents & Kits, Testing ...
April 21, 2026
Based on market forecasts, the advanced drug delivery sector will expand from USD 245.64 billion in 2024 to USD 385.14 billion by 2034, experiencing a CAGR of 4.6%. In 2023, oral drug delivery led the market with a 48% share, while controlled release...
April 07, 2026
Small Molecule Drug Discovery Outsourcing Market (By Drug Discovery Phase: Target Identification & Validation, Hit Identification, Hit-to-Lead (H2L), Lead Optimization, Preclinical Development; By Service Type: Medicinal Chemistry Services, Biolo...
April 21, 2026
According to market projections, the global drug-eluting balloon catheters market, valued at USD 1.42 billion in 2024, is anticipated to reach USD 4.02 billion by 2034, growing at a CAGR of 11.1% over the next decade. The increasing cases of cardiova...
April 21, 2026
Market insights predict the global cell signaling industry will increase from USD 6.58 billion in 2024 to USD 14.11 billion by 2034, achieving a CAGR of 7.92%. Growing research and development in healthcare is promoting the use of cell signaling....
January 16, 2026
According to market projections, the global AI in drug discovery market, valued at USD 19.89 billion in 2025, is anticipated to reach USD 160.49 billion by 2035, growing at a CAGR of 23.22% over the next decade. North America leads AI in drug discove...
April 07, 2026
High Potency Active Pharmaceutical Ingredients Market ( By Product: Synthetic, Biotech; By Manufacturer Type: In-house, Outsourced; By Drug Type: Innovative, Generic; By Application: Oncology, Hormonal, Glaucoma, Others; By Region: North America, Asi...
April 21, 2026
Market insights predict, the cell-based assays industry is expected to grow from USD 18.8 billion in 2025 to USD 43.9 billion by 2035, driven by a CAGR of 8.84%. The cell-based assays market is growing because it is mainly applied in drug discovery a...
April 21, 2026
Market insights predict, the non-small cell lung cancer therapeutics industry is expected to grow from USD 21.5 billion in 2024 to USD 71.2 billion by 2034, driven by a CAGR of 12.74%. The non-small cell lung cancer therapeutics market is expanding d...
April 21, 2026
Projections indicate that, the global ankylosing spondylitis market will increase from USD 6.7 billion in 2025 to USD 11.83 billion by 2035, experiencing a CAGR of 5.85% over the next 10 years. The rising prevalence of autoimmune disorders and growin...
April 07, 2026
Drug Discovery Market ( By Functional Workflow/Stage: Hit identification, Target discovery & validation, Hit-to-lead & lead optimization, Biologics discovery, Preclinical candidate selection & IND-enabling studies, Translational & bio...
April 21, 2026
Projections indicate that, AI in pharmaceuticals industry is projected to rise from USD 1.97 billion in 2025 to USD 21.51 billion by 2035, reflecting a CAGR of 27.01% over the next decade. The AI in the pharmaceutical market is growing as demand for ...
February 03, 2026
Projections indicate that, the global organoids and spheroids market will increase from USD 1.22 billion in 2025 to USD 9.77 billion by 2035, experiencing a CAGR of 23.13% over the next 10 years. Advances in genome editing technologies, automation, m...
April 21, 2026
Market insights predict, the investigational new drug CDMO industry is expected to grow from USD 5.66 billion in 2025 to USD 11.10 billion by 2035, driven by a CAGR of 6.97%. The investigational new drug CDMO market is expanding due to increasing dev...
April 21, 2026
Rising advantages of AI and ML in the world are reducing timelines, cost-effective approaches in drug discovery and clinical trials are driving the global market. North America was dominant in the market due to technological advancements by using AI ...
April 21, 2026
According to market projections, the therapeutic drug monitoring (TDM) sector is expected to grow from USD 1.92 billion in 2024 to USD 2.8 billion by 2034, reflecting a CAGR of 3.84%. Globally, the rising prevalence of chronic diseases, along with th...
April 21, 2026
Based on market forecasts, the global drug discovery platforms market, projected at USD 186.24 million in 2024, is expected to reach USD 635.45 million by 2034, growing at a CAGR of 13.44% over the forecast period. Drug discovery platforms use smart ...
April 21, 2026
According to forecasts, the global lipid nanoparticle raw materials market will grow from USD 300.72 million in 2025 to USD 522.01 million by 2035, with an expected CAGR of 5.67%. The need for better drug delivery systems for enhanced performance dri...
April 21, 2026
Based on market forecasts, the originator drug sector will expand from USD 24.54 billion in 2024 to USD 50.05 billion by 2034, experiencing a CAGR of 7.44%.The originator market is growing due to rising research in drug development. North America&r...
February 17, 2026
According to our forecasts, the drug delivery CDMO market is set for strong growth from 2026 to 2035, driven by rising chronic diseases, expanding biologics and GLP-1 therapies, and increasing outsourcing by pharmaceutical and biotech companies....
April 02, 2026
Cell and Gene Therapy Drug Delivery Devices Market ( By Product / Device Type: Infusion Systems & Pumps, Prefilled Syringes & Vials, Autoinjectors & Wearable Injectors, Apheresis & Collection Kits / Administration Kits, Closed System ...
April 21, 2026
Projections indicate that, the global generative AI in drug discovery market will increase from USD 250 million in 2024 to USD 2847.43 million by 2034, experiencing a CAGR of 27.42% over the next 10 years. The generative AI in drug discovery market i...
April 10, 2026
Biotechnology and Pharmaceutical Services Outsourcing Market (By Service: Consulting, Regulatory Affairs, Product Design & Development, Auditing and Assessment, Product Maintenance, Training & Education, Others; By End Use: Pharmaceutical Com...
April 21, 2026
Advantages of ML in drug discovery, including raised efficiency and prediction rates, are accelerating the drug discovery process as growing cases of various diseases are fueling the expansion of the market across the world. Whereas North America dom...
April 14, 2026
Pharmaceutical Hot Melt Extrusion Market (By Type: Twin-Screw Extruder, Single-Screw Extruder; By Application:Pharma Companies, Contract Manufacturing Organizations (CMOs), Research Laboratories, Others;By Dosage Form: Solid Dosage Forms, Semi-Solid/...
February 23, 2026
According to our forecasts, the drug discovery informatics market was valued at USD 4.12 billion in 2025 and is expected to reach USD 4.6 billion in 2026, further expanding to USD 12.39 billion by 2035, growing at a strong CAGR of 11.64% from 2026 to...
April 21, 2026
Market insights predict the global radionuclide drug conjugates (RDC) industry will increase from USD 3.24 billion in 2024 to USD 8.87 billion by 2034, achieving a CAGR of 10.54%. The global radionuclide drug conjugates (RDC) market is growing stro...
February 17, 2026
Our projections indicate that, the drug desensitization market was valued at USD 670.03 million in 2025 and is estimated to reach USD 724.57 million in 2026, further projected to grow to USD 1,465.41 million by 2035, expanding at a CAGR of 8.14% duri...
April 21, 2026
Expansion of healthcare facilities, especially in emerging economies, is improving access to advanced cancer treatments, further supporting market expansion. North America has a robust healthcare system with significant spending on advanced treatme...
April 21, 2026
Market insights predict the global antibiotic-coated surgical implant drug industry will increase from USD 1.17 billion in 2024 to USD 3.05 billion by 2034, achieving a CAGR of 10.05%. The increasing number of surgeries and the rising prevalence of...
April 09, 2026
Smart Drug Delivery Systems Market (By Product Type: Inhalers, Smart Injectable Devices, Smart Infusion Pumps, Connected Drug Delivery Devices, Implantable Drug Delivery Systems, Transdermal Drug Delivery Systems; By Technology: IoT-based Systems, Bl...
April 21, 2026
According to market projections, the global bio-based propylene glycol market, valued at USD 289.25 million in 2024, is anticipated to reach USD 837.57 million by 2034, growing at a CAGR of 11.25% over the next decade. The growing new drug discovery ...
April 21, 2026
The drug discovery SaaS platforms market is growing as mainly used in the drug discovery process for virtual screening, data management and analysis, AI-powered drug design, facilitating collaboration, clinical trial optimization, drug repurposing, t...
April 21, 2026
Projections indicate that, the global bronchitis treatment market will increase from USD 6.85 billion in 2024 to USD 11.45 billion by 2034, experiencing a CAGR of 5.28% over the next 10 years. The market is driven by growing COPD cases (due to air po...
April 21, 2026
The market is growing due to increasing globalization of trade and rising demand for efficient, technology-driven logistics solutions. Digitalization and automation are further enhancing speed, transparency, and cost-effectiveness in supply chain ope...
March 16, 2026
According to forecasts, the global intranasal drug delivery devices market will grow from USD 1.91 billion in 2025 to USD 4.98 billion by 2035, with an expected CAGR of 10.04%. The intranasal drug delivery devices market is growing as it provides rap...
February 18, 2026
According to our projections, the clinical trial drug sourcing market was valued at USD 2.07 billion in 2025 and reached USD 2.16 billion in 2026, projected to grow to USD 3.14 billion by 2035, expanding at a CAGR of 4.24% (2026–2035)....
April 21, 2026
Market insights predict, the drug discovery as a service industry is expected to grow from USD 21.3 billion in 2024 to USD 79.82 billion by 2034, driven by a CAGR of 14.17%. The drug discovery as a service market is expanding due to increasing cancer...
April 21, 2026
According to market statistics data, the comparator drug sourcing industry is projected to grow from US$ 1.16 billion in 2023 to US$ 2.24 billion by 2034, driven by rising clinical trials and R&D. Central sourcing, AI integration, and expanding...
April 21, 2026
According to market estimations, the molecular interaction analyzer sector size to capture US$ 337.7 million in 2025 is to soar US$ 454.1 million by 2030. The molecular interaction analyzer market is driven by increasing demand for proteomics researc...
April 21, 2026
According to market estimations, the global thrombopoietin receptor agonists industry, valued at US$ 1.85 billion in 2023, is set to reach US$ 3.74 billion by 2034, driven by rising platelet-related disorders like ITP and AML. Key trends include FD...
April 21, 2026
According to market projections, the radiation-induced dermatitis drug sector is expected to grow from USD 510 million in 2024 to USD 729.2 million by 2034, reflecting a CAGR of 3.64%. The growing need for radiation therapy and the increasing develop...
February 16, 2026
According to our market insight calculation, the decentralized & digitalized clinical trials market was valued at USD 8.71 billion in 2025 and is projected to grow from USD 9.36 billion in 2026 to USD 17.92 billion by 2035, expanding at a CAGR of...
April 21, 2026
Based on market forecasts, the life science chemical biotech instrumentation sector will expand from USD 34.23 billion in 2024 to USD 50.85 billion by 2034, experiencing a CAGR of 4.05%. The growing research and development activities and technologic...
January 23, 2026
According to our projections, the acne drugs market is comprehensively analyzed covering global market size valued at USD 10.78 billion in 2026 and projected to reach USD 17.07 billion by 2035, growing at a CAGR of 5.24%...
April 21, 2026
According to market projections, the generic drugs industry is expected to grow from USD 513.02 billion in 2025 to USD 859.84 billion by 2035, driven by a CAGR of 5.3%, driven by the need to reduce healthcare costs. North America leads the market, wh...
April 21, 2026
According to market projections, the oncology drugs sector is expected to grow from USD 204.39 billion in 2024 to USD 360.79 billion by 2034, reflecting a CAGR of 6.29%. The oncology drugs market is growing due to the increasing incidence of cancer, ...
April 21, 2026
According to market projections, the pain management drugs sector is expected to grow from USD 84.1 billion in 2024 to USD 126.17 billion by 2034, reflecting a CAGR of 4.14%. The rising prevalence of chronic pain and growing research and development ...
January 23, 2026
According to our projections, the migraine drugs market is projected to grow from USD 8.43 billion in 2026 to approximately USD 21.46 billion by 2035, at a CAGR of 10.94%....
January 22, 2026
According to our forecasts, the antiviral drugs market was valued at USD 65.13 billion in 2026 and is projected to reach approximately USD 89.86 billion by 2035, growing at a CAGR of 3.64% during the forecast period....
February 26, 2026
According to market projections, the nucleic acid drugs sector is expected to grow from USD 57.03 million in 2025 to USD 348.45 million by 2035, reflecting a CAGR of 19.84%. The nucleic acid drugs market is expanding due to advances in delivery techn...
April 21, 2026
Market insights predict, the antitumor ADC drugs industry is expected to grow from USD 7.38 billion in 2025 to USD 24.75 billion by 2035, driven by a CAGR of 12.86%. Rising cancer incidence/unmet needs have driven the growth of the market. North Amer...
February 23, 2026
Based on market forecasts, the global ophthalmology drugs market, projected at USD 45.52 billion in 2025, is expected to reach USD 76.51 billion by 2035, growing at a CAGR of 5.33% over the forecast period. The ophthalmology drugs market is growing...
April 21, 2026
Projections indicate that, hyperkalemia drugs industry is projected to rise from USD 1.42 billion in 2025 to USD 5.20 billion by 2035, reflecting a CAGR of 13.84% over the next decade. The market is growing due to the rising prevalence of chronic kid...
April 21, 2026
According to market projections, the global anticancer drugs market, valued at USD 167.09 billion in 2024, is anticipated to reach USD 401.32 billion by 2034, growing at a CAGR of 9.14% over the next decade. The growing aging population is more susce...
April 21, 2026
Market insights predict the global cancer supportive care drugs industry will increase from USD 21.89 billion in 2024 to USD 27.05 billion by 2034, achieving a CAGR of 2.14%. The increased focus on the prevention and management of the adverse effects...
April 21, 2026
Projections indicate that, the global anti-hypertensive drugs market will increase from USD 26.76 billion in 2025 to USD 39.2 billion by 2035, experiencing a CAGR of 3.89% over the next 10 years. Market growth is driven by the rising prevalence of hy...
January 21, 2026
Projections indicate that, the global anti-obesity drugs market will increase from USD 9.11 billion in 2025 to USD 99.74 billion by 2035, experiencing a CAGR of 27.04% over the next 10 years. In 2024, North America led the anti-obesity drugs market, ...
April 02, 2026
Veterinary Ophthalmic Drugs Market (By Drug Class: Anti-infectives, Anti-inflammatory drugs, Anti-glaucoma drugs, Lubricants & artificial Tears, Others; By Animal Type: Companion Animals, Livestock Animals; By Indication: Conjuctivities, Keratiti...
April 21, 2026
Based on market forecasts, the biosynthesis peptide drugs sector will expand from USD 18.31 billion in 2024 to USD 32.88 billion by 2034, experiencing a CAGR of 6.26%. The biosynthesis peptide drugs market is growing, as these drugs offer many advant...
January 19, 2026
According to market projections, the diabetes drugs sector is expected to grow from USD 75.16 billion in 2025 to USD 143.76 billion by 2035, reflecting a CAGR of 6.7%. The diabetes drugs market is growing due to the rising global prevalence of diabet...
April 21, 2026
According to market projections, the hyperlipidemia drugs sector is expected to grow from USD 24.47 billion in 2025 to USD 31.49 billion by 2034, reflecting a CAGR of 2.84%. In 2024, North America led the global hyperlipidemia drugs market, with stat...
April 21, 2026
Based on market forecasts, the global gastrointestinal drugs market, projected at USD 40.21 billion in 2024, is expected to reach USD 55.85 billion by 2034, growing at a CAGR of 3.34% over the forecast period. The gastrointestinal drugs market is gro...
April 21, 2026
According to forecasts, the global respiratory drugs market will grow from USD 17.53 billion in 2024 to USD 30.81 billion by 2034, with an expected CAGR of 5.8%. In 2023, COPD was the most common respiratory disorder, leading the market with a 36% sh...
April 21, 2026
According to market projections, the global insulin drugs and delivery devices market, valued at USD 23.75 billion in 2024, is anticipated to reach USD 49.18 billion by 2034, growing at a CAGR of 7.65% over the next decade. The rising prevalence of d...
April 21, 2026
According to market projections, the global 3D printed drugs market, valued at USD 131.25 million in 2025, is anticipated to reach USD 547.36 million by 2035, growing at a CAGR of 15.35% over the next decade. In 2024, North America led the 3D printed...
January 19, 2026
According to forecasts, the global asthma and COPD drugs market will grow to USD 70.27 billion by 2035, with an expected CAGR of 5.01%. In 2024, King's College London showed that benralizumab can reduce hospitalizations in severe asthma and treat ast...
April 21, 2026
According to market projections, the global antipyretic and analgesic drugs market, valued at USD 47.47 billion in 2024, is anticipated to reach USD 77.99 billion by 2034, growing at a CAGR of 5.09% over the next decade. The rising prevalence of feve...
April 21, 2026
Market insights predict, the epilepsy drugs industry is expected to grow from USD 9.98 billion in 2024 to USD 16.42 billion by 2034, driven by a CAGR of 5.1%. Epilepsy drugs help control seizures by stabilizing brain activity. They work by reducing e...
April 21, 2026
According to forecasts, the global HIV drugs market size will grow from USD 34.75 billion in 2024 to USD 52.95 billion by 2034, with an expected CAGR of 4.3%. In 2023, combination-class drugs led the HIV drugs market with a 60% share, while hospital ...
April 21, 2026
Eltrombopag Drugs Market: In October 2024, Jiaheng (Zhuhai Hengqin) Pharmaceutical Technology Company Limited gained approval from China's National Medical Products Administration to market Eltrombopag Olamine tablets. Additionally, in November 2023,...
April 21, 2026
The advanced liver cancer treatment drugs market is expanding due to increased adoption of systemic therapies over traditional chemotherapy and growing approvals of immuno-oncology agents. North America led the market due to the presence of a well-de...
April 21, 2026
The chemical synthesis peptide drugs market is valued at US$ 2.74 billion in 2025 and is projected to reach US$ 4.82 billion by 2034, growing at a CAGR of 6.54%. Key segments include synthesis methods (chemical, non-chemical), technologies (SPPS, LPP...
April 21, 2026
According to forecasts, the global cardiovascular drugs market will grow from USD 150.02 billion in 2024 to USD 213.36 billion by 2034, with an expected CAGR of 3.65%. The cardiovascular drugs market is expanding due to growing early diagnosis as wel...
April 21, 2026
AI in clinical trials for drugs market is growing due to its use in clinical research to monitor and improve medication adherence. This is particularly through the use of applications, such as facial, digital biomarkers, and vocal expression. AI redu...
April 21, 2026
The anesthesia drugs market size is calculated at $0.669 bn in 2025 is to hit $2.058 bn by 2034. The anesthesia drugs market is growing due to rising surgical procedures, advancements in anesthesia techniques, and increasing demand for outpatient sur...
January 13, 2026
Market insights predict the global rheumatoid arthritis drugs industry will increase from USD 19.55 billion in 2025 to USD 30.65 billion by 2035, achieving a CAGR of 4.6%. Rheumatoid arthritis (RA) drugs help reduce pain, swelling, and joint damage b...
April 13, 2026
Genitourinary Drugs Market (By Indication: Prostate Cancer, Ovarian Cancer, Bladder Cancer, Cervical Cancer, Renal Cancer, Erectile Dysfunction, Urinary Tract Infections, Urinary Incontinence & Overactive Bladder, Sexually Transmitted Diseases, I...
April 21, 2026
According to market projections, the U.S. pain management drugs sector is expected to grow from USD 31.84 billion in 2024 to USD 44.92 billion by 2034, reflecting a CAGR of 3.64%. The U.S. pain management drugs market is growing due to rising cases o...
April 21, 2026
Projections indicate that, anti-inflammatory drugs industry is projected to rise from USD 122.32 billion in 2024 to USD 274.79 billion by 2034, reflecting a CAGR of 8.43% over the next decade. In 2024, North America led the anti-inflammatory drugs ma...
April 21, 2026
According to forecasts, the global antipsychotic drugs market will grow from USD 19.45 billion in 2024 to USD 41.21 billion by 2034, with an expected CAGR of 7.8%. Antipsychotic drugs help manage symptoms of mental health conditions like schizophreni...
April 21, 2026
According to market projections, the global liver cancer drugs market, valued at USD 3.05 billion in 2024, is anticipated to reach USD 11.5 billion by 2034, growing at a CAGR of 14.2% over the next decade. Liver cancer drugs are medicines used to tre...
April 09, 2026
Drugs Market ( By Product Type: Prescription Drugs Over-the-Counter (OTC) Drugs; By Therapeutic Area: Oncology, Cardiovascular, Central Nervous System, Respiratory, Infectious Diseases, Gastrointestinal, Diabetes, Autoimmune Disorders, Dermatology, O...
February 03, 2026
Based on market forecasts, the global Non-steroidal anti-inflammatory drugs market, projected at USD 23.16 billion in 2025, is expected to reach USD 37.73 billion by 2035, growing at a CAGR of 5% over the forecast period. Arthritis dominated the NSAI...
April 21, 2026
The market is growing due to its ability to accelerate drug discovery and optimize personalized treatment strategies. This leads to faster development timelines, reduced costs, and improved patient outcomes....
April 21, 2026
The organ transplant immunosuppressant drugs market size is calculated at $5.81 bn in 2025 is to hit $8.82 bn by 2034. In 2024, Eledon Pharmaceuticals showed positive trial results for tegoprubart in islet transplant recipients with type 1 diabetes. ...
April 21, 2026
Market insights predict the global inhalation and nasal spray generic drugs industry will increase from USD 25.18 billion in 2025 to USD 59.35 billion by 2035, achieving a CAGR of 8.99%. The inhalation and nasal spray generic drugs market is expandin...
April 21, 2026
According to market projections, the GLP-1 drugs sector is expected to grow from USD 52.95 billion in 2025 to USD 132.79 billion by 2035, reflecting a CAGR of 9.63%. The GLP-1 drugs market is expanding due to increasing incidences of type 2 diabetes ...
April 21, 2026
According to market projections, the U.S. oncology drugs sector is expected to grow from USD 95.69 billion in 2024 to USD 246.85 billion by 2034, reflecting a CAGR of 9.94%. The extensive research, scientific innovations, and the market penetration...
April 14, 2026
Brain Tumor Drugs Market (By Therapy: Targeted Therapy, Chemotherapy, Immunotherapy, Others; By Indication: Pituitary, Meningioma, Glioma, Others; By Distribution Channel: Hospital Pharmacy, Retail & Online Pharmacy, By Region: North America, Asi...
April 21, 2026
Based on market forecasts, the targeted drugs for allergic diseases sector will expand from USD 13.96 billion in 2024 to USD 30.22 billion by 2034, experiencing a CAGR of 8.06%. The targeted drugs for allergic diseases market is growing due to rising...
April 21, 2026
Market insights predict the global pediatric drugs industry will increase from USD 144.88 billion in 2024 to USD 458.09 billion by 2034, achieving a CAGR of 12.2%. Pediatric drugs are medicines specially designed for children to treat illnesses, mana...
April 21, 2026
According to market projections, the global sinusitis drugs market, valued at USD 2.33 billion in 2025, is anticipated to reach USD 4.16 billion by 2035, growing at a CAGR of 5.96% over the next decade. The growing research activities and increasing ...
April 21, 2026
According to market projections, the antimalarial drugs sector is expected to grow from USD 1.07 billion in 2024 to USD 1.67 billion by 2034, reflecting a CAGR of 4.57%. Establishing awareness and government programs are propelling the global market ...
April 21, 2026
According to market projections, the global over-the-counter or OTC drugs market, valued at USD 142.27 billion in 2025, is anticipated to reach USD 268.32 billion by 2035, growing at a CAGR of 6.55% over the next decade. In 2024, North America led th...
April 21, 2026
According to market projections, the global pulmonary arterial hypertension drugs market, valued at USD 8.04 billion in 2024, is anticipated to reach USD 12.38 billion by 2034, growing at a CAGR of 4.44% over the next decade. The market is growing du...
February 20, 2026
Based on our estimations, the intravenous iron drugs market was valued at USD 3.65 billion in 2025 and reached USD 3.98 billion in 2026, and is projected to grow to USD 8.74 billion by 2035, expanding at a CAGR of 9.14% (2026–2035)....
April 21, 2026
According to forecasts, the global age-related macular degeneration (AMD) drugs market will grow from USD 10.57 billion in 2024 to USD 29.04 billion by 2034, with an expected CAGR of 10.66%. Rising patient demand for a better quality of life is estim...
April 21, 2026
According to market projections, the pelvic inflammatory disease treatment sector is expected to grow from USD 3.52 billion in 2024 to USD 5.09 billion by 2034, reflecting a CAGR of 3.75%. In 2024, North America led the global pelvic inflammatory dis...
April 21, 2026
According to market estimations the global leuprorelin drugs market, valued at US$ 2.60 billion in 2023, is projected to reach US$ 4.78 billion by 2034, driven by rising cancer cases and gender-affirming surgeries. North America leads the market, w...
February 19, 2026
According to our forecasts, the invasive fungal disease (IFD) drugs market was valued at USD 3.11 billion in 2025 and is projected to grow from USD 3.29 billion in 2026 to USD 5.34 billion by 2035, expanding at a CAGR of 5.55% during 2026–2035....
April 21, 2026
According to market projections, the immuno-oncology drugs sector is expected to grow from USD 94 billion in 2024 to USD 421.27 billion by 2034, reflecting a CAGR of 16.34%. Across the globe, a rising number of cancer patients is associated with the ...
April 21, 2026
According to market projections, the global biopharmaceutical contract manufacturing market, valued at USD 40.14 billion in 2024, is anticipated to reach USD 115.65 billion by 2034, growing at a CAGR of 11.14% over the next decade.The biopharmaceut...
+1 9197 992 333
+91 93077 85324
sales@towardshealthcare.com